OrsoBio specializes in creating novel biopharmaceuticals aimed at addressing unmet medical needs in patients with metabolic disorders.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/06/2024 | Series B | $67MM | $xx.xx | $316.32MM | Ascenta Capital, Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
94,140,791
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ascenta Capital, Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital, Woodline Partners
|
||||||
11/07/2023 | Series A-1 | $17.98MM | $xx.xx | $162.58MM | Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
54,482,685
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital
|
||||||
11/07/2023 | Series A | $66.65MM | $xx.xx | $162.58MM | Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
148,111,321
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Eli Lilly & Company, Enavate Sciences, Longitude Capital, NuevaBio, Samsara Biocapital
|
||||||
06/30/2022 | Series Seed | $5MM | $xx.xx | $33.2MM | NuevaBio, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
20,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
NuevaBio, Samsara Biocapital
|
||||||
06/30/2022 | Series Seed-1 | $10MM | $xx.xx | $33.2MM | NuevaBio, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
30,303,030
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
NuevaBio, Samsara Biocapital
|